ACBD6 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	18 studies	28% ± 13%	Explore
fibroblast	13 studies	25% ± 8%	Explore
astrocyte	11 studies	34% ± 16%	Explore
glutamatergic neuron	10 studies	48% ± 24%	Explore
microglial cell	10 studies	29% ± 10%	Explore
GABAergic neuron	9 studies	44% ± 22%	Explore
oligodendrocyte precursor cell	9 studies	36% ± 14%	Explore
oligodendrocyte	9 studies	35% ± 13%	Explore
natural killer cell	8 studies	19% ± 2%	Explore
epithelial cell	8 studies	31% ± 16%	Explore
macrophage	8 studies	31% ± 11%	Explore
B cell	7 studies	21% ± 6%	Explore
pericyte	7 studies	27% ± 13%	Explore
smooth muscle cell	7 studies	21% ± 4%	Explore
adipocyte	7 studies	25% ± 6%	Explore
dendritic cell	7 studies	24% ± 10%	Explore
endothelial cell of lymphatic vessel	7 studies	29% ± 8%	Explore
interneuron	6 studies	56% ± 22%	Explore
myofibroblast cell	6 studies	21% ± 6%	Explore
myeloid cell	6 studies	26% ± 4%	Explore
hematopoietic precursor cell	5 studies	25% ± 11%	Explore
CD4-positive, alpha-beta T cell	5 studies	20% ± 2%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	18% ± 2%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	5 studies	17% ± 2%	Explore
neuron	5 studies	39% ± 18%	Explore
amacrine cell	5 studies	32% ± 6%	Explore
retina horizontal cell	5 studies	25% ± 6%	Explore
retinal cone cell	5 studies	27% ± 8%	Explore
mast cell	5 studies	27% ± 5%	Explore
ciliated cell	5 studies	27% ± 6%	Explore
type I pneumocyte	5 studies	26% ± 8%	Explore
type II pneumocyte	5 studies	28% ± 7%	Explore
CD8-positive, alpha-beta T cell	5 studies	17% ± 1%	Explore
club cell	5 studies	26% ± 9%	Explore
CD16-negative, CD56-bright natural killer cell, human	4 studies	18% ± 2%	Explore
granule cell	4 studies	36% ± 7%	Explore
retinal ganglion cell	4 studies	34% ± 5%	Explore
retinal bipolar neuron	4 studies	24% ± 7%	Explore
cardiac muscle cell	4 studies	22% ± 2%	Explore
lymphocyte	4 studies	26% ± 6%	Explore
basal cell	4 studies	40% ± 16%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	3 studies	20% ± 5%	Explore
non-classical monocyte	3 studies	22% ± 7%	Explore
GABAergic interneuron	3 studies	42% ± 5%	Explore
progenitor cell	3 studies	28% ± 3%	Explore
placental villous trophoblast	3 studies	30% ± 10%	Explore
retinal pigment epithelial cell	3 studies	29% ± 15%	Explore
GABAergic amacrine cell	3 studies	34% ± 8%	Explore
Mueller cell	3 studies	23% ± 5%	Explore
OFF-bipolar cell	3 studies	39% ± 13%	Explore
glycinergic amacrine cell	3 studies	31% ± 9%	Explore
T cell	3 studies	21% ± 4%	Explore
abnormal cell	3 studies	31% ± 18%	Explore
hematopoietic stem cell	3 studies	25% ± 5%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	39% ± 10%	Explore
monocyte	3 studies	24% ± 4%	Explore
alveolar macrophage	3 studies	28% ± 8%	Explore
respiratory goblet cell	3 studies	30% ± 12%	Explore
goblet cell	3 studies	28% ± 14%	Explore
transit amplifying cell	3 studies	37% ± 25%	Explore
plasmacytoid dendritic cell	3 studies	21% ± 2%	Explore
mucus secreting cell	3 studies	23% ± 3%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
brain	14 studies	40% ± 22%	Explore
heart	4 studies	19% ± 2%	Explore
lung	4 studies	28% ± 9%	Explore
peripheral blood	3 studies	20% ± 4%	Explore
eye	3 studies	33% ± 14%	Explore
placenta	3 studies	19% ± 2%	Explore
adipose	3 studies	27% ± 3%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
breast	100%	2029.31	459 / 459	100%	22.38	1118 / 1118
esophagus	100%	1668.19	1445 / 1445	100%	12.82	183 / 183
intestine	100%	1968.72	966 / 966	100%	15.68	527 / 527
ovary	100%	2572.39	180 / 180	100%	16.31	430 / 430
pancreas	100%	1360.97	328 / 328	100%	14.93	178 / 178
prostate	100%	2229.03	245 / 245	100%	15.12	502 / 502
skin	100%	2282.58	1809 / 1809	100%	20.44	472 / 472
uterus	100%	2431.19	170 / 170	100%	22.05	459 / 459
kidney	100%	1896.52	89 / 89	100%	12.77	900 / 901
thymus	100%	2439.59	653 / 653	100%	15.67	604 / 605
bladder	100%	2155.38	21 / 21	100%	18.21	503 / 504
lung	100%	1785.39	577 / 578	100%	17.13	1154 / 1155
brain	100%	1619.45	2629 / 2642	100%	18.98	705 / 705
adrenal gland	100%	1948.37	258 / 258	99%	12.01	228 / 230
stomach	100%	1355.40	359 / 359	99%	13.71	283 / 286
liver	100%	859.88	225 / 226	99%	12.95	403 / 406
adipose	100%	1822.44	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	15.49	80 / 80
lymph node	0%	0	0 / 0	100%	25.23	29 / 29
spleen	100%	2439.31	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	17.39	45 / 45
ureter	0%	0	0 / 0	100%	15.98	1 / 1
blood vessel	100%	1918.07	1334 / 1335	0%	0	0 / 0
muscle	99%	1057.25	796 / 803	0%	0	0 / 0
heart	98%	1177.87	843 / 861	0%	0	0 / 0
peripheral blood	92%	1645.80	857 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0005829	Cellular component	cytosol
GO_0005515	Molecular function	protein binding
GO_0000062	Molecular function	fatty-acyl-CoA binding

IV. Literature review

[source]

Gene name	ACBD6
Protein name	Acyl-CoA-binding domain-containing protein 6
Synonyms
Description	FUNCTION: Binds long-chain acyl-coenzyme A molecules with a strong preference for unsaturated C18:1-CoA, lower affinity for unsaturated C20:4-CoA, and very weak affinity for saturated C16:0-CoA. Does not bind fatty acids. .
Accessions	ENST00000367595.4 Q9BR61 ENST00000645415.1 A0A2R8Y544 ENST00000642319.1

ACBD6 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review